Selected article for: "cytometry analysis flow and flow cytometry"
Author: McLeod, Robbie L.; Angagaw, Minilik H.; Baral, Toya Nath; Liu, Liming; Moniz, Raymond Joseph; Laskey, Jason; Hsieh, SuChun; Lee, Mike; Han, Jin-Hwan; Issafras, Hassan; Javaid, Sarah; Loboda, Andrey; Sadekova, Svetlana; O'Connor, Joann A.; Tse, Archie; Punnonen, Juha
Title: Characterization of murine CEACAM1 in vivo reveals low expression on CD8(+) T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1
  • Document date: 2018_10_2
    • ID: 01id7jq6_23
    Snippet: We next studied the possibility that the CC1 Ab modulated the phenotypes of tumor infiltrating immune cells. Flow cytometry analysis of tumor-infiltrating cells freshly isolated from syngeneic tumors revealed no changes in the proportions of CD4+, CD8+ T cells, Treg cells, NK cells, B cells, monocytes, dendritic cells or myeloid-derived suppressor cells (myeloid or granulocytic) upon CC1 treatment. In addition, no phenotypic changes were observed.....
    Document: We next studied the possibility that the CC1 Ab modulated the phenotypes of tumor infiltrating immune cells. Flow cytometry analysis of tumor-infiltrating cells freshly isolated from syngeneic tumors revealed no changes in the proportions of CD4+, CD8+ T cells, Treg cells, NK cells, B cells, monocytes, dendritic cells or myeloid-derived suppressor cells (myeloid or granulocytic) upon CC1 treatment. In addition, no phenotypic changes were observed in tumor infiltrating T cells derived from mice treated with CC1 as a monotherapy or in combination with the anti-PD-1 Ab.

    Search related documents:
    Co phrase search for related documents
    • anti Ab combination and syngeneic tumor: 1
    • CC1 treatment and syngeneic tumor: 1, 2, 3
    • dendritic cell and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dendritic cell and NK cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • dendritic cell and suppressor cell: 1
    • flow cytometry analysis and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • flow cytometry analysis and NK cell: 1, 2, 3, 4
    • flow cytometry analysis and suppressor cell: 1
    • immune cell and NK cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune cell and suppressor cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • immune cell and syngeneic tumor: 1
    • NK cell and suppressor cell: 1